Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Receivables (2016 - 2025)

cbdMD's Receivables history spans 9 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Receivables rose 77.11% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, up 77.11%, while the annual FY2025 figure was $786449.0, 20.07% down from the prior year.
  • Receivables for Q4 2025 was $1.1 million at cbdMD, up from $1.0 million in the prior quarter.
  • Across five years, Receivables topped out at $2.0 million in Q1 2022 and bottomed at $576901.0 in Q4 2023.
  • The 5-year median for Receivables is $1.1 million (2021), against an average of $1.1 million.
  • The largest annual shift saw Receivables soared 179.0% in 2021 before it plummeted 43.22% in 2023.
  • A 5-year view of Receivables shows it stood at $1.1 million in 2021, then fell by 18.95% to $898720.0 in 2022, then tumbled by 35.81% to $576901.0 in 2023, then increased by 9.38% to $631033.0 in 2024, then surged by 77.11% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Receivables are $1.1 million (Q4 2025), $1.0 million (Q3 2025), and $967310.0 (Q2 2025).